Advances in the treatment of lysosomal storage disease
- 1 September 2001
- journal article
- Published by Wiley in Developmental Medicine and Child Neurology
- Vol. 43 (9) , 639-646
- https://doi.org/10.1111/j.1469-8749.2001.tb00249.x
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- Comparative Efficacy of Dose Regimens in Enzyme Replacement Therapy of Type I Gaucher DiseaseBlood Cells, Molecules, and Diseases, 2000
- Sandhoff disease in Cyprus: population screening by biochemical and DNA analysis indicates a high frequency of carriers in the Maronite communityHuman Genetics, 2000
- Cathepsin K gene mutations and 1q21 haplotypes in patients with pycnodysostosis in an outbred populationEuropean Journal of Human Genetics, 2000
- Niemann-Pick diseaseCurrent Opinion in Hematology, 2000
- Glycoprotein lysosomal storage disorders: α- and β-mannosidosis, fucosidosis and α-N-acetylgalactosaminidase deficiencyBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1999
- Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centresArchives of Disease in Childhood, 1997
- Theearly andlate processing of lysosomal enzymes: Proteolysis and compartmentationCellular and Molecular Life Sciences, 1992
- Sphingolipid activator protein 1 deficiency in metachromatic leucodystrophy with normal arylsulphatase A activity. A clinical, morphological, biochemical and immunological studyEuropean Journal of Pediatrics, 1991
- REVERSAL OF CLINICAL FEATURES OF HURLER'S DISEASE AND BIOCHEMICAL IMPROVEMENT AFTER TREATMENT BY BONE-MARROW TRANSPLANTATIONThe Lancet, 1981
- Genetic heterogeneity in human neuraminidase deficiencyNature, 1980